Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07521280

State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain

Feasibility and Preliminary Clinical Evaluation of a State-Based Load Tolerance and Rule-Based Individualized Rehabilitation Pathway in Youth Athletes With Current or Previous Lower-Extremity Apophyseal Pain

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Medical University of Gdansk · Academic / Other
Sex
All
Age
10 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if a state-based rehabilitation program is feasible and helpful for children and adolescents with current or past lower-extremity apophyseal pain, including Osgood-Schlatter-related knee pain and Sever-related heel pain. It will also learn about how well participants follow the program and whether the program can be delivered as planned. The main questions it aims to answer are: 1. Can this rehabilitation program be delivered with good attendance, good home-exercise adherence, and complete follow-up data? 2. Do pain, function, and sports participation improve during the rehabilitation period? All participants will receive the rehabilitation pathway. The program is adjusted to each participant's clinical presentation, pain irritability, activity limits, and main physical deficits. Participants will: * Attend baseline and follow-up physiotherapy assessments * Receive a rehabilitation plan that includes education, pain and load monitoring, and individualized exercises * Complete home exercises and keep a short symptom and activity log * Attend in-person physiotherapy sessions during the rehabilitation period * Answer questionnaires about pain, function, and sports participation during follow-up

Detailed description

This study evaluates a structured rehabilitation pathway for youth athletes with current or previous lower-extremity apophyseal pain, including Osgood-Schlatter-related knee pain and Sever-related heel pain. The rehabilitation pathway combines a state-based early load-management framework with a rule-based individualized exercise program and education for safe return to sport. The rehabilitation pathway is built around the Load Tolerance and Participation (LTP) Module. This module is used to classify each participant's current clinical state before rehabilitation progression. Classification is based on symptom irritability, participation restriction, clinical complexity, and recent load history. The purpose of this classification is to guide early decisions about activity modification, pain monitoring, exercise starting level, and progression or temporary regression of loading. All participants in this study receive the same overall rehabilitation framework. However, the content is individualized using predefined decision rules rather than clinician preference alone. Each participant receives: (1) a mandatory core module focused on pain/load tolerance, education, and activity modification; (2) one main deficit-targeted exercise module, selected according to baseline clinical findings; and (3) an optional additional module only when a second deficit is clearly present and clinically relevant. Deficit-targeted modules may address range of motion/flexibility, strength, or motor control. This study includes three pre-specified rehabilitation entry pathways. The first pathway includes participants who enter rehabilitation after completing the separate 2-week sham-controlled photobiomodulation trial (NCT07446517). The second pathway includes participants with active apophyseal pain who are not enrolled in that trial and enter rehabilitation directly after baseline assessment. The third pathway includes participants with a history of Osgood-Schlatter-related or Sever-related symptoms, or those with low-irritability/residual presentations, who enter rehabilitation directly in a lower-intensity or simplified pathway. These pathways are defined at study entry and will be used for pre-specified exploratory subgroup analyses. They are not intended to support causal comparisons of treatment effectiveness between groups. The rehabilitation phase includes in-person physiotherapy visits and a home exercise program. During follow-up, participants and families are instructed in pain monitoring, symptom-guided activity modification, weekly tracking of symptoms and sport exposure, and safe stepwise return to sport. Rehabilitation progression is guided by predefined pain-monitoring rules and trend monitoring across time, rather than by fixed timelines alone. This rehabilitation study is methodologically linked to the separately registered pilot sham-controlled photobiomodulation trial in youth athletes with apophyseal pain. Participants who complete that trial may enter this rehabilitation study through the post-trial pathway. However, the present study is focused on the rehabilitation pathway itself and is registered separately because the rehabilitation intervention, timing of entry, and clinical questions differ from those of the photobiomodulation trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALState-Based Rehabilitation PathwayThis intervention is a structured rehabilitation program for youth athletes with current or previous lower-extremity apophyseal pain, including Osgood-Schlatter-related knee pain and Sever-related heel pain. The program combines education, pain and load monitoring, activity modification, and a rule-based individualized exercise program. Rehabilitation is guided by a state-based clinical framework, including symptom irritability, participation restriction, recent load history, maturation context, and clinical complexity. All participants receive the same overall rehabilitation pathway, including a core pain/load-tolerance module, and may also receive one main deficit-targeted exercise module, with an optional additional module when clinically indicated. Deficit-targeted modules may address range of motion/flexibility, strength, or dynamic control and balance. Progression and temporary regression are determined by pre-defined clinical decision rules rather than fixed timelines.

Timeline

Start date
2026-04-05
Primary completion
2027-04-05
Completion
2029-04-05
First posted
2026-04-09
Last updated
2026-04-09

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07521280. Inclusion in this directory is not an endorsement.